Skip to main content
Addgene
Showing: 101 - 120 of 940 results
  1. pAAV-hSyn Con/Fon hChR2(H134R)-EYFP (AAV9)

    Viral Prep
    #55645-AAV9
    Purpose
    Ready-to-use AAV9 particles produced from pAAV-hSyn Con/Fon hChR2(H134R)-EYFP (#55645). In addition to the viral particles, you will also receive purified pAAV-hSyn Con/Fon hChR2(H134R)-EYFP plasmid DNA. Synapsin-driven, Cre-dependent and Flp-dependent channelrhodopsin-EYFP expression for optogenetic activation. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Promoter
    Syn
    Tags
    EYFP (Cre- and Flp-dependent)
    Available since
    June 8, 2020
    Availability
    Academic Institutions and Nonprofits only
  2. pAAV-Ef1a-DIO hChR2(E123T/T159C)-EYFP (AAV5)

    Viral Prep
    #35509-AAV5
    Purpose
    Ready-to-use AAV5 particles produced from pAAV-Ef1a-DIO hChR2(E123T/T159C)-EYFP (#35509). In addition to the viral particles, you will also receive purified pAAV-Ef1a-DIO hChR2(E123T/T159C)-EYFP plasmid DNA. EF1a-driven, Cre-dependent, humanized channelrhodopsin E123T/T159C mutant fused to EYFP for optogenetic activation. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Promoter
    EF1a
    Tags
    EYFP (Cre-dependent)
    Available since
    Feb. 21, 2018
    Availability
    Academic Institutions and Nonprofits only
  3. pAAV-CaMKIIa-eNpHR 3.0-EYFP (AAV9)

    Viral Prep
    #26971-AAV9
    Purpose
    Ready-to-use AAV9 particles produced from pAAV-CaMKIIa-eNpHR 3.0-EYFP (#26971). In addition to the viral particles, you will also receive purified pAAV-CaMKIIa-eNpHR 3.0-EYFP plasmid DNA. CaMKIIa-driven eNpHR 3.0-EYFP for optogenetic inhibition. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Promoter
    CaMKII
    Tags
    EYFP
    Available since
    March 30, 2018
    Availability
    Academic Institutions and Nonprofits only
  4. pAAV-CAG-tdTomato (codon diversified) (AAV PHP.eB)

    Viral Prep
    #59462-PHPeB
    Purpose
    Ready-to-use AAV PHP.eB particles produced from pAAV-CAG-tdTomato (codon diversified) (#59462). In addition to the viral particles, you will also receive purified pAAV-CAG-tdTomato (codon diversified) plasmid DNA. CAG-driven tdTomato expression control. These AAV were produced with the PHPeB serotype, which permits efficient transduction of the central nervous system. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Promoter
    CAG
    Tags
    tdTomato (codon diversified)
    Available since
    Feb. 28, 2018
    Availability
    Academic Institutions and Nonprofits only
  5. pAAV-hSyn-DIO-EGFP (AAV1)

    Viral Prep
    #50457-AAV1
    Purpose
    Ready-to-use AAV1 particles produced from pAAV-hSyn-DIO-EGFP (#50457). In addition to the viral particles, you will also receive purified pAAV-hSyn-DIO-EGFP plasmid DNA. hSyn-driven, Cre-dependent EGFP expression. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Promoter
    Syn
    Tags
    EGFP (Cre-dependent)
    Available since
    Feb. 18, 2020
    Availability
    Academic Institutions and Nonprofits only
  6. pAAV.GFAP.Cre.WPRE.hGH (AAV5)

    Viral Prep
    #105550-AAV5
    Purpose
    Ready-to-use AAV5 particles produced from pAAV.GFAP.Cre.WPRE.hGH (#105550). In addition to the viral particles, you will also receive purified pAAV.GFAP.Cre.WPRE.hGH plasmid DNA. GFAP-driven Cre expression. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Promoter
    GFAP
    Tags
    None
    Available since
    July 26, 2018
    Availability
    Academic Institutions and Nonprofits only
  7. pAAV-EF1a-double floxed-hChR2(H134R)-mCherry-WPRE-HGHpA (AAV8)

    Viral Prep
    #20297-AAV8
    Purpose
    Ready-to-use AAV8 particles produced from pAAV-EF1a-double floxed-hChR2(H134R)-mCherry-WPRE-HGHpA (#20297). In addition to the viral particles, you will also receive purified pAAV-EF1a-double floxed-hChR2(H134R)-mCherry-WPRE-HGHpA plasmid DNA. Humanized channelrhodopsin H134R mutant fused to mCherry, driven by the EF1a promoter. Cre-dependent. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Promoter
    EF1a
    Tags
    mCherry (Cre-dependent)
    Available since
    Dec. 18, 2017
    Availability
    Academic Institutions and Nonprofits only
  8. pAAV.CMV.PI.EGFP.WPRE.bGH (AAV9)

    Viral Prep
    #105530-AAV9
    Purpose
    Ready-to-use AAV9 particles produced from pAAV.CMV.PI.EGFP.WPRE.bGH (#105530). In addition to the viral particles, you will also receive purified pAAV.CMV.PI.EGFP.WPRE.bGH plasmid DNA. CMV-driven EGFP control. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Promoter
    CMV
    Tags
    EGFP
    Available since
    July 13, 2018
    Availability
    Academic Institutions and Nonprofits only
  9. pAAV_hSyn-DIO-PdCO-mScarlet-WPRE (AAV5)

    Viral Prep
    #198511-AAV5
    Purpose
    Ready-to-use AAV5 particles produced from pAAV_hSyn-DIO-PdCO-mScarlet-WPRE (#198511). In addition to the viral particles, you will also receive purified pAAV_hSyn-DIO-PdCO-mScarlet-WPRE plasmid DNA. Syn-driven Cre-dependent expression of optimized PdCO in frame with mScarlet. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Promoter
    Syn
    Tags
    mScarlet (Cre-dependent)
    Available since
    Sept. 27, 2024
    Availability
    Academic Institutions and Nonprofits only
  10. pAAV-FLEX-tdTomato (AAV PHP.eB)

    Viral Prep
    #28306-PHPeB
    Purpose
    Ready-to-use AAV PHP.eB particles produced from pAAV-FLEX-tdTomato (#28306). In addition to the viral particles, you will also receive purified pAAV-FLEX-tdTomato plasmid DNA. CAG-driven, Cre-dependent tdTomato expression control. These AAV were produced with the PHPeB serotype, which permits efficient transduction of the central nervous system. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Promoter
    CAG
    Tags
    tdTomato (Cre-dependent)
    Available since
    Feb. 28, 2018
    Availability
    Academic Institutions and Nonprofits only
  11. pAAV-CaMKIIa(0.4)-eOPN3-mScarlet-WPRE (AAV1)

    Viral Prep
    #125712-AAV1
    Purpose
    Ready-to-use AAV1 particles produced from pAAV-CaMKIIa(0.4)-eOPN3-mScarlet-WPRE (#125712). In addition to the viral particles, you will also receive purified pAAV-CaMKIIa(0.4)-eOPN3-mScarlet-WPRE plasmid DNA. CaMKIIa-driven expression of the optimized mosquito OPN3 rhodopsin in-frame with mScarlet. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Promoter
    short version of αCamKinase II promoter (0.4kb)
    Tags
    mScarlet
    Available since
    June 26, 2024
    Availability
    Academic Institutions and Nonprofits only
  12. pAAV-CAG-SomaGCaMP6f2 (AAV9)

    Viral Prep
    #158757-AAV9
    Purpose
    Ready-to-use AAV9 particles produced from pAAV-CAG-SomaGCaMP6f2 (#158757). In addition to the viral particles, you will also receive purified pAAV-CAG-SomaGCaMP6f2 plasmid DNA. CAG-driven expression of soma-targeting GCaMP6f2. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Promoter
    CAG promoter
    Tags
    None
    Available since
    Jan. 6, 2022
    Availability
    Academic Institutions and Nonprofits only
  13. pAAV-GFAP-hM4D(Gi)-mCherry (AAV5)

    Viral Prep
    #50479-AAV5
    Purpose
    Ready-to-use AAV5 particles produced from pAAV-GFAP-hM4D(Gi)-mCherry (#50479). In addition to the viral particles, you will also receive purified pAAV-GFAP-hM4D(Gi)-mCherry plasmid DNA. GFAP-driven hM4D(Gi) receptor with an mCherry reporter for CNO-induced neuronal silencing. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Promoter
    GFAP
    Tags
    mCherry
    Available since
    June 8, 2018
    Availability
    Academic Institutions and Nonprofits only
  14. pAAV-CaMKIIa-hChR2(H134R)-EYFP (AAV5)

    Viral Prep
    #26969-AAV5
    Purpose
    Ready-to-use AAV5 particles produced from pAAV-CaMKIIa-hChR2(H134R)-EYFP (#26969). In addition to the viral particles, you will also receive purified pAAV-CaMKIIa-hChR2(H134R)-EYFP plasmid DNA. CaMKIIa-driven, humanized channelrhodopsin H134R mutant fused to EYFP for optogenetic activation. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Promoter
    CaMKII
    Tags
    EYFP
    Available since
    March 7, 2018
    Availability
    Academic Institutions and Nonprofits only
  15. pAAV.hSyn.FLEX.iGluSnFR3.v857.GPI.codonopt (AAV1)

    Viral Prep
    #175181-AAV1
    Purpose
    Ready-to-use AAV1 particles produced from pAAV.hSyn.FLEX.iGluSnFR3.v857.GPI.codonopt (#175181). In addition to the viral particles, you will also receive purified pAAV.hSyn.FLEX.iGluSnFR3.v857.GPI.codonopt plasmid DNA. Synapsin-driven, Cre-dependent, third generation glutamate sensor iGluSnFR3, variant 857. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Promoter
    Syn
    Tags
    None
    Available since
    May 16, 2023
    Availability
    Academic Institutions and Nonprofits only
  16. pAAV-hSyn-DIO-hM4D(Gi)-mCherry (AAV5)

    Viral Prep
    #44362-AAV5
    Purpose
    Ready-to-use AAV5 particles produced from pAAV-hSyn-DIO-hM4D(Gi)-mCherry (#44362). In addition to the viral particles, you will also receive purified pAAV-hSyn-DIO-hM4D(Gi)-mCherry plasmid DNA. Syn-driven, Cre-dependent hM4D(Gi) receptor with an mCherry reporter for CNO-induced neuronal silencing. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Promoter
    Syn
    Tags
    mCherry (Cre-dependent)
    Available since
    Dec. 1, 2016
    Availability
    Academic Institutions and Nonprofits only
  17. pAAV-CaMKIIa-EGFP (AAV1)

    Viral Prep
    #50469-AAV1
    Purpose
    Ready-to-use AAV1 particles produced from pAAV-CaMKIIa-EGFP (#50469). In addition to the viral particles, you will also receive purified pAAV-CaMKIIa-EGFP plasmid DNA. CamKIIa-driven EGFP expression control. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Promoter
    CaMKII
    Tags
    EGFP
    Available since
    Sept. 27, 2024
    Availability
    Academic Institutions and Nonprofits only
  18. pENN.AAV.hSyn.Cre.WPRE.hGH (AAV5)

    Viral Prep
    #105553-AAV5
    Purpose
    Ready-to-use AAV5 particles produced from pENN.AAV.hSyn.Cre.WPRE.hGH (#105553). In addition to the viral particles, you will also receive purified pENN.AAV.hSyn.Cre.WPRE.hGH plasmid DNA. hSyn-driven Cre expression. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Promoter
    Syn
    Tags
    None
    Available since
    May 31, 2019
    Availability
    Academic Institutions and Nonprofits only
  19. pAAV-hSyn-DIO-hM3D(Gq)-mCherry (AAV PHP.eB)

    Viral Prep
    #44361-PHPeB
    Purpose
    Ready-to-use AAV PHP.eB particles produced from pAAV-hSyn-DIO-hM3D(Gq)-mCherry (#44361). In addition to the viral particles, you will also receive purified pAAV-hSyn-DIO-hM3D(Gq)-mCherry plasmid DNA. Syn-driven, Cre-dependent, hM3D(Gq) receptor with an mCherry reporter for CNO-induced neuronal activation. These AAV were produced with the PHP.eB serotype, which permits efficient transduction of the central nervous system. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Promoter
    Syn
    Tags
    mCherry (Cre-dependent)
    Available since
    March 22, 2018
    Availability
    Academic Institutions and Nonprofits only
  20. pAAV-CaMKIIa-hM3D(Gq)-mCherry (AAV5)

    Viral Prep
    #50476-AAV5
    Purpose
    Ready-to-use AAV5 particles produced from pAAV-CaMKIIa-hM3D(Gq)-mCherry (#50476). In addition to the viral particles, you will also receive purified pAAV-CaMKIIa-hM3D(Gq)-mCherry plasmid DNA. CaMKIIa-driven hM3D(Gq) receptor with an mCherry reporter for CNO-induced neuronal activation. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Promoter
    CaMKII
    Tags
    mCherry
    Available since
    Nov. 21, 2016
    Availability
    Academic Institutions and Nonprofits only
Showing: 101 - 120 of 940 results